OTLK
Outlook Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.79 / 10
Netural
Fund‑flow metrics are strong (7.57/10) with positive inflows across most investor sizes, though extra‑large funds are net negative. Sentiment is neutral. Analyst coverage is limited to one Strong Buy recommendation, but its historical win rate is only 25%, making the outlook mixed.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-11
InstitutionAscendiant Capital
Times predicted4
Historical Win Rate25.0%
What is the market sentiment for OTLK?
- OTLK holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.79/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
